Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
UK Minister Defends US Pharma Deal Following Calls to Scrap It
A trade deal with the US that increases the price Britain pays for new medicines will help patients and not cause hundreds of thousands of additional deaths, according to UK Technology Secretary Liz Kendall. Kendall said an analysis published last…
Pharma Buying Trends: Longer Decisions, More Stakeholders
The way pharma companies choose their suppliers has fundamentally shifted and it's essentially to understanding them all. Decision-making has become longer, more collaborative, and far more rigorous, with larger cross-functional teams and formal…
Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger
2 Biotechs Making Waves With A Single Product in their Pipeline Catalyst Pharmaceuticals NASDAQ: CPRX stockholders approved the company's proposed merger with Angelini Pharma S.p.A. at a special meeting held virtually on July 8, according to…
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of 'Moderate Buy' by Brokerages
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the twenty-four research firms that are presently covering the company, MarketBeat reports. One equities research…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1622 GMT – The failure of Wainua, a heart disease drug developed by AstraZeneca and Ionis, to meet a…
Markets surge in early trade, Sensex up by 800 pts
Stock market benchmark indices Sensex and Nifty surged in early trade on Friday, driven by a rally in IT firms after TCS reported an increase in its June-quarter net profit and guided towards an improvement in demand returning in the ongoing…
Sensex, Nifty Surge: Reliance, IT Stocks Drive Market Rally Amid Easing Crude Prices
Indian benchmark indices Sensex and Nifty extended their winning streak for a second day, with the Sensex soaring over 800 points, fuelled by strong performances from key heavyweights, easing crude oil prices, and positive earnings reports from the…
The Club's top 10 things to watch in the stock market Friday
Our top 10 things to watch on Friday, July 10 1. S & P futures are flat on Friday morning, but the broad-based index is on pace for a weekly gain. Stocks rallied on Thursday after President Donald Trump said Iran had called to make a deal. Despite…
Indian Stock Market Surges: Sensex Jumps 700 Points on IT Sector Rally, TCS Q1 Results
Indian stock markets witnessed a robust surge in early trade, with the Sensex jumping nearly 700 points, as IT sector stocks rallied following strong June-quarter results from TCS and positive global market cues. Indian benchmark indices Sensex and…
BSE Sensex: Top gainers today
From the Sensex pack, Reliance Industries, Tech Mahindra, Bharat Electronics, Axis Bank, Tata Steel and Infosys were among the major winners. TCS ended 1 per cent higher after the country's largest IT services company on Thursday reported a 4.61…
Markets rally for second day; Sensex jumps over 800 points
Stock market benchmark indices Sensex and Nifty ended 1% higher on Friday (July 10, 2026), taking their winning run to the second day, helped by a rally in heavyweights Reliance Industries, ICICI Bank and HDFC Bank. Easing crude oil prices and…
Healthcare Investing: Finding Growth Beyond Pharmaceuticals
Investors are often drawn to healthcare for its innovation and long-term growth potential. From new surgical technologies to life-saving treatments, healthcare companies produce some of the economy's most exciting advancements. We believe…
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
Kailera Therapeutics Inc. (NASDAQ: KLRA) is one of the best IPO stocks with huge upside potential. On July 7, Kailera Therapeutics announced positive topline results from two Phase 3 clinical trials conducted by Hengrui Pharma for…
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC
Abivax's latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without backing from Big Pharma, its CEO told CNBC on Friday. The French biotech has been under intense scrutiny as an acquisition target by a…
Sensex jumps over 800 points!
Stock market benchmark indices Sensex and Nifty ended 1 per cent higher on Friday, taking their winning run to the second day, helped by a rally in heavyweights Reliance Industries, ICICI Bank and HDFC Bank. Easing crude oil prices and buying in IT…
Receive a Daily briefing on Pharma Industry News
Get Started